Solid Tumor
Quiénes somos
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
KN035 for dMMR/MSI-H Advanced Solid Tumors
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
QUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
Investigación clínica de células CAR-NK específicas de ROBO1 en pacientes con tumores sólidos
Un estudio de fase Ib/IIa de CR6086 en combinación con balstilimab en pacientes con cáncer colorrectal metastásico pMMR-MSS
Un ensayo de ipatasertib en combinación con atezolizumab
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors